These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 18332710

  • 1. Evaluation and management of steroid-unresponsive nephrotic syndrome.
    Del Rio M, Kaskel F.
    Curr Opin Pediatr; 2008 Apr; 20(2):151-6. PubMed ID: 18332710
    [Abstract] [Full Text] [Related]

  • 2. Evaluation and management of steroid-sensitive nephrotic syndrome.
    Hodson EM, Alexander SI.
    Curr Opin Pediatr; 2008 Apr; 20(2):145-50. PubMed ID: 18332709
    [Abstract] [Full Text] [Related]

  • 3. The treatment of idiopathic focal segmental glomerulosclerosis in adults.
    Hogan J, Radhakrishnan J.
    Adv Chronic Kidney Dis; 2014 Sep; 21(5):434-41. PubMed ID: 25168833
    [Abstract] [Full Text] [Related]

  • 4. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
    Sinha A, Gupta A, Kalaivani M, Hari P, Dinda AK, Bagga A.
    Kidney Int; 2017 Jul; 92(1):248-257. PubMed ID: 28318625
    [Abstract] [Full Text] [Related]

  • 5. Use of sirolimus in patients with primary steroid-resistant nephrotic syndrome.
    Liern M, De Reyes V, Fayad A, Vallejo G.
    Nefrologia; 2012 May 14; 32(3):321-8. PubMed ID: 22508141
    [Abstract] [Full Text] [Related]

  • 6. [Nephrotic syndrome in childhood].
    Reusz G, Szabó A, Fekete A.
    Orv Hetil; 2006 Nov 26; 147(47):2251-60. PubMed ID: 17380687
    [Abstract] [Full Text] [Related]

  • 7. Other immunosuppressive agents for focal segmental glomerulosclerosis.
    Ponticelli C, Passerini P.
    Semin Nephrol; 2003 Mar 26; 23(2):242-8. PubMed ID: 12704585
    [Abstract] [Full Text] [Related]

  • 8. Effect of immunoadsorption on refractory idiopathic focal and segmental glomerulosclerosis.
    Kuhn C, Kuhn A, Markau S, Kästner U, Osten B.
    J Clin Apher; 2006 Dec 26; 21(4):266-70. PubMed ID: 17120233
    [Abstract] [Full Text] [Related]

  • 9. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
    Gulati A, Sinha A, Gupta A, Kanitkar M, Sreenivas V, Sharma J, Mantan M, Agarwal I, Dinda AK, Hari P, Bagga A.
    Kidney Int; 2012 Nov 26; 82(10):1130-5. PubMed ID: 22763815
    [Abstract] [Full Text] [Related]

  • 10. Cyclosporin therapy for steroid resistant nephrotic focal glomerulosclerosis.
    Windom HH, Fisher M, Neale TJ.
    N Z Med J; 1990 Mar 28; 103(886):125-6. PubMed ID: 2320338
    [Abstract] [Full Text] [Related]

  • 11. Difficult-to-treat idiopathic nephrotic syndrome: established drugs, open questions and future options.
    Kemper MJ, Valentin L, van Husen M.
    Pediatr Nephrol; 2018 Oct 28; 33(10):1641-1649. PubMed ID: 28879428
    [Abstract] [Full Text] [Related]

  • 12. The Treatment with Mycophenolate Mofetil of Corticoresistent Nephrotic Syndrome by Idiopathic Focal Segmental Glomerulosclerosis: Analysis of Twenty Cases.
    Rroji M, Spahia N, Barbullushi M, Sasdelli M.
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 Dec 01; 40(3):135-137. PubMed ID: 32109210
    [No Abstract] [Full Text] [Related]

  • 13. Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort.
    Trautmann A, Bodria M, Ozaltin F, Gheisari A, Melk A, Azocar M, Anarat A, Caliskan S, Emma F, Gellermann J, Oh J, Baskin E, Ksiazek J, Remuzzi G, Erdogan O, Akman S, Dusek J, Davitaia T, Özkaya O, Papachristou F, Firszt-Adamczyk A, Urasinski T, Testa S, Krmar RT, Hyla-Klekot L, Pasini A, Özcakar ZB, Sallay P, Cakar N, Galanti M, Terzic J, Aoun B, Caldas Afonso A, Szymanik-Grzelak H, Lipska BS, Schnaidt S, Schaefer F, PodoNet Consortium.
    Clin J Am Soc Nephrol; 2015 Apr 07; 10(4):592-600. PubMed ID: 25635037
    [Abstract] [Full Text] [Related]

  • 14. Effective therapy of a child case of refractory nephrotic syndrome with tacrolimus.
    Tsugawa K, Tanaka H, Nakahata T, Ito E.
    Tohoku J Exp Med; 2004 Nov 07; 204(3):237-41. PubMed ID: 15502424
    [Abstract] [Full Text] [Related]

  • 15. [Immunity and immunosuppression in childhood idiopathic nephrotic syndrome].
    Frange P, Frey MA, Deschênes G.
    Arch Pediatr; 2005 Mar 07; 12(3):305-15. PubMed ID: 15734130
    [Abstract] [Full Text] [Related]

  • 16. Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: a reappraisal.
    Geary DF, Farine M, Thorner P, Baumal R.
    Clin Nephrol; 1984 Sep 07; 22(3):109-13. PubMed ID: 6488594
    [Abstract] [Full Text] [Related]

  • 17. [Immunosuppressive therapy for nephrotic syndrome and strategy for adverse side effects from that therapy].
    Takeda Y, Tomino Y.
    Nihon Rinsho; 2004 Oct 07; 62(10):1875-9. PubMed ID: 15500133
    [Abstract] [Full Text] [Related]

  • 18. Cyclosporin A in steroid-sensitive nephrotic syndrome with frequent relapses.
    Chan MK, Cheng IK.
    Postgrad Med J; 1987 Sep 07; 63(743):757-9. PubMed ID: 3444800
    [Abstract] [Full Text] [Related]

  • 19. Treatment of focal segmental glomerulosclerosis.
    Meyrier A.
    Expert Opin Pharmacother; 2005 Aug 07; 6(9):1539-49. PubMed ID: 16086641
    [Abstract] [Full Text] [Related]

  • 20. Tacrolimus-induced HUS: an unusual cause of acute renal failure in nephrotic syndrome.
    Pandirikkal VB, Jain M, Gulati S.
    Pediatr Nephrol; 2007 Feb 07; 22(2):298-300. PubMed ID: 17123120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.